![]() |
Volumn 1, Issue 5, 2013, Pages 296-302
|
NY-ESO-1 expression in meningioma suggests a rationale for new immunotherapeutic approaches
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER ANTIBODY;
CTAG1B PROTEIN, HUMAN;
MEMBRANE PROTEIN;
TUMOR ANTIGEN;
ADOLESCENT;
ADULT;
AGED;
BIOSYNTHESIS;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
IMMUNOHISTOCHEMISTRY;
IMMUNOLOGY;
IMMUNOTHERAPY;
MALE;
MENINGEAL NEOPLASMS;
MENINGIOMA;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PROCEDURES;
VERY ELDERLY;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBODIES, NEOPLASM;
ANTIGENS, NEOPLASM;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IMMUNOTHERAPY;
MALE;
MEMBRANE PROTEINS;
MENINGEAL NEOPLASMS;
MENINGIOMA;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
YOUNG ADULT;
|
EID: 84921307286
PISSN: None
EISSN: 23266074
Source Type: Journal
DOI: 10.1158/2326-6066.CIR-13-0029 Document Type: Article |
Times cited : (14)
|
References (0)
|